Advanced and intuitive methods for the visualization and con
Medyria AG
Incorporated
18.01.2012Headquarters
WinterthurSupport
Medyria has developed a unique technology for the direct measurement of the Blood Flow Velocity (BFV) and is developing medical devices that integrates the BFV sensor.
Recently we started the development of the PyCath, the only microcatheter on the planet earth that allows the full assessment of the heart physiology with a direct blood flow velocity measurement. This has a huge benefit for all patients, because completes the common coronary coronary study with an assessment of the microcirculation, bringing the eligibility of angina pectoris patients from 50% to 100%.
Besides this main project Medyria offers its sensing technology though an OEM business model that is successfully leading to the development of new cardiovascular devices functioning on the BFV measurement.
News
Medyria secures CHF 1.5M to advance PyCath development and expand globally (venturelab.swiss)
Medyria secures CHF 1.5 million to accelerate development of its medical device (startupticker.ch)
Milestones achievements for life sciences startups (startupticker.ch)
Sparks IPO Academy prepares new cohort for next move (startupticker.ch)
Medyria secures CHF 3.7 million to bring novel diagnostic device closer to market entry (venturelab.swiss)
Medyria raises CHF3.7 million to bring its diagnostic device closer to market entry (startupticker.ch)
Venture Leaders 2019 Teams Celebrated at the US Embassy in Switzerland (venturelab.swiss)
Four Swiss startups to explore China (startupticker.ch)
A few lessons and thoughts from the Venture Leaders Life Sciences roadshow in Boston, 9-15 June 2019 by Danuta Cichocka (venturelab.swiss)
Meet Venture Leader Mauro Sette's Endovascular Catheter Navigation's Startup (venturelab.swiss)
10 Winners of Venture Leaders Life Sciences Selected (startupticker.ch)
Medyria First in Man Clinical Trial well under way (startupticker.ch)
Medyria closes series B round and receives approval for first-in-man clinical trial (startupticker.ch)
Three New CTI Start-up Label Companies (startupticker.ch)
Medyria AG closes Series A Funding Round of CHF 2.2 million (startupticker.ch)
Pionierpreis 2014: Die 3 Finalisten stehen fest (startupticker.ch)
11 companies selected for the next Swiss Venture Day (startupticker.ch)
CEO Day 2013: a huge and efficient event - updated (startupticker.ch)
Milestones news
Pre-Clinical Phase concluded
Pre-Clinical phase concluded
Close 3.7 M Equity round
OEM Development agreement signed
Professor Stephan Haulon as Medyria Clinical Study Report Independent Reviewer
Medyria finalized the 40 patient enrollment in First in Human Germany based Clinical trial
Medyria First in Man Clinical Trial enrolled 25 patients successfully
Medyria certified ISO 13485 with NSAI
Dr. med. Jörg Teßarek as Independent CRF reviewer of Medyria First in Human Clinical Trial
Videos and Presentations
SCSN 2019
Trackcath Video